Systematic assessment of difficult-to-treat asthma

European Respiratory Journal

Volumn 22, Issue 3, 2003, Pages 478-483

  Robinson, D S ^a   Campbell, D A ^b   Durham, S R ^a   Pfeffer, J ^b   Barnes, P J ^a   Chung, K F ^a   Adcock, I ^a   Belvisi, M ^a   Cullinan, P ^a   Giembycz, M ^a   Hansel, T ^a   Jeffery, P ^a   Johnston, S ^a   Jones, M ^a   Kay, A B ^a   Larche, M ^a   Newman Taylor, A ^a   Rogers, D ^a   Openshaw, P ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Adherence; Diagnosis; Psychiatry; Severe asthma

Indexed keywords

ACETYLSALICYLIC ACID; BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; GLUCOCORTICOID; HYDROCORTISONE; IPRATROPIUM BROMIDE; LONG ACTING DRUG; PREDNISOLONE; SALBUTAMOL; TERBUTALINE; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; DIAGNOSTIC ERROR; DRUG BLOOD LEVEL; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OPEN STUDY; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; STATISTICAL SIGNIFICANCE; UNITED KINGDOM;

ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA; BECLOMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; LUNG DISEASES; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PREDNISOLONE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS;

EID: 10744224453     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00017003     Document Type: Article

References (23)

1. British Thoracic Society, British Paediatric Society, Research Unit of Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. The British Guidelines on Asthma Management: 1995 Review and Position Statement. Thorax 1997; 52: S1-S21.
2. Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J 1998; 12: 1209-1218.
3. Wareham NJ, Harrison BD, Jenkins PF, Nicholls J, Stableforth DE. A district confidential enquiry into deaths due to asthma. Thorax 1993; 48: 1117-1120.
4. Ayres JG, Miles JF, Barnes PJ. Brittle asthma. Thorax 1998; 53: 315-321.
5. Szefler SJ, Leung DY. Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management. Eur Respir J 1997; 10: 1640-1647.
6. Shiner RJ, Nunn AJ, Chung KF, Geddes DM. Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma. Lancet 1990; 336: 137-140.
7. Alexander AG, Barnes NC, Kay AB. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet 1992; 339: 324-328.
8. Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999; 160: 1001-1008.
9. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 160: 1532-1539.
10. Proceedings of the ATS Workshop on Refractory Asthma. Current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2001; 162: 2341-2351.
11. Chung KF, Godard P, Adelroth E, et al. Difficult/therapy resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-resistant asthma. Eur Respir J 1999; 13: 1198-1208.
12. Jones PW, Quirk FH, Chloe M, Baveystock M, Littlejonhs PA. Self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-1327.
13. Goldberg D, Rickels K, Dowing R, Hesbacher P. A comparison of two psychiatric screening tests. Br J Psych 1976; 129: 61-67.
14. Carr DH, Hibon S, Rubens M, Chung KF. Peripheral airways obstruction on high-resolution computed tomography in chronic severe asthma. Respir Med 1998; 92: 448-453.
15. Higgins BG, Britton JR, Chinn S, et al. The distribution of peak expiratory flow variability in a population sample. Am Rev Respir Dis 1989; 146: 1368-1372.
16. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001; 164: 744-748.
17. Chan MTS, Leung DYM, Szefler SJ, Spahn JD. Difficult to control asthma: clinical characteristics of steroid insensitive asthma. J Allergy Clin Immunol 1998; 101: 594-601.
18. Corrigan CJ, Brown PH, Barnes NC, et al. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 1991; 144: 1016-1025.
19. Payne DN, Wilson NM, James A, Hablas H, Agrafioti C, Bush A. Evidence for different subgroups of difficult asthma. Thorax 2001; 56: 345-350.
20. Miles JF, Garden GM, Tunnicliffe WS, Cayton RM, Ayres JG. Psychological morbidity and coping skills in patients with brittle and non-brittle asthma: a case-control study. Clin Exp Allergy 1997; 27: 1151-1159.
21. Fireman P. Rhinitis and asthma connection: management of coexisting upper airway allergic diseases and asthma. Allergy Asthma Proc 2000; 21: 45-54.
22. Bousquet J, Van Cauwenberge P. Allergic rhinitis and its impact on asthma (ARIA). J Allergy Clin Immunol 2001; 108: S1-S147.
23. Tunnicliffe WS, Fletcher TJ, Hammond K, et al. Sensitivity and exposure to indoor allergens in adults with differing asthma severity. Eur Respir J 1999; 13: 654-659.